Panel: Collective Action, Real Results: The Power of Partnership on Scope 3 Emissions

Tackling Scope 3 emissions – those indirect emissions that occur in a company’s value chain – is one of the greatest sustainability challenges facing the pharmaceutical sector. No single company can achieve Net-Zero targets alone. This panel explores how cross-industry collaboration, data transparency, and the right technology partners are helping pharma make real progress.

How companies are overcoming barriers to sharing Scope 3 emissions data with suppliers and partners.

Strategies for getting suppliers aligned on decarbonisation goals and reporting standards.

A spotlight on tools like Manufacture 2030 and how they are enabling scalable, verified emissions tracking and reduction efforts.